Actio Biosciences, a biotechnology firm focused on utilizing a novel genetic and precision medicine platform to create therapeutics for both rare and common diseases, has appointed Dr. Dimitrios Arkilo as Chief Medical Officer (CMO). Dr. Arkilo, a pediatric neurologist with…
Amplitude Vascular Systems (AVS), a medical device company specializing in treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy (IVL) platform, has announced a strategic partnership with the Jacobs Institute, a nonprofit medical device innovation center in Buffalo, N.Y.,…
Weave (NYSE: WEAV), a top all-in-one customer experience and payments platform, has clinched its fourth consecutive Dental Product Shopper Readers’ Choice Award for both Patient Communication and Dental Analytics software. Dental Product Shopper, a leading publication in the dental industry,…
QuantHealth, an AI-driven clinical trial design firm, has successfully simulated over 100 trials, achieving 85% accuracy and notable returns on investment for pharmaceutical partners. By utilizing its proprietary technology and patient-focused solutions, the company tackles the common issue of trial…
Relief Mental Health, a top provider of transcranial magnetic stimulation (TMS), psychedelic therapy (including SPRAVATO® and IV ketamine), psychiatry, and talk therapy, has introduced TMS for smoking cessation at its Oak Brook, IL clinic. Relief Mental Health is now offering…
HistoSonics has closed an oversubscribed $102 million Series D financing round, led by Alpha Wave Ventures. New investors Amzak Health and HealthQuest Capital joined existing backers Johnson & Johnson Innovation – JJDC, Inc., Venture Investors, Lumira Ventures, Yonjin Venture, and…
DermBiont, a clinical-stage biotech company specializing in innovative topical treatments for rare oncology and dermatology conditions, has reported promising initial results from its open-label, multi-center Phase 2a trial for basal cell carcinoma (BCC). Following these positive findings, DermBiont is shifting…
AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted by the FDA for Priority Review. This application, based on the positive ADRIATIC Phase III trial results in patients with limited-stage small cell lung cancer (LS-SCLC) whose disease…
Commonwealth Care Alliance (CCA) has expanded its provider agreement with Beth Israel Lahey Health (BILH) to enhance care access for its Senior Care Options (SCO) and One Care members. This expanded network will serve approximately 20 towns and cities in…
Trilliant Health, a top analytics firm in the healthcare sector, has introduced a free version of its Provider Directory application. This user-friendly tool offers a centralized source for precise and up-to-date information on millions of healthcare providers and is now…
Alpenglow Biosciences, a pioneer in 3D spatial biology, has recently received contracts from the Advanced Research Projects Agency for Health (ARPA-H) and the National Institutes of Health (NIH). Additionally, the company has secured further investment to advance the development of…
Success Beyond Game Day and SHREDmill have partnered to integrate AI-driven mindset training into XPE’s SHREDmill platform and online community. This collaboration seeks to elevate the overall development of athletes by incorporating advanced mental training into their speed training programs,…